ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

Therapeutic Potentials of Poly (ADP-Ribose) Polymerase 1 (PARP1) Inhibition in Multiple Sclerosis and Animal Models: Concept Revisiting.

Yan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.